Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;33:60-65

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cicogna, A. C.
Right arrow Articles by Bing, O. H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cicogna, A. C.
Right arrow Articles by Bing, O. H. L.
Related Collections
Right arrow Animal models of human disease
Right arrow Heart failure - basic studies

(Hypertension. 1999;33:60-65.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Direct Effects of Colchicine on Myocardial Function

Studies in Hypertrophied and Failing Spontaneously Hypertensive Rats

Antonio C. Cicogna; Kathleen G. Robinson; Chester H. Conrad; Krishna Singh; Robyn Squire; Marina P. Okoshi; Oscar H. L. Bing

From the Faculdade de Medicina de Botucatu—UNESP (A.C.C., M.P.O.), Brazil; and the Department of Veterans Affairs Medical Center (K.G.R., C.H.C., R.S., O.H.L.B.), Boston, Mass; and the Department of Cardiology, Boston Medical Center (K.S.), Mass.

Correspondence to Antonio Carlos Cicogna, Departamento de Clínica Médica, Faculdade de Medicina de Botucatu—UNESP, Rubião Júnior, S/N, CEP: 18618-000, Botucatu, SP, Brazil. E-mail cicogna{at}fmb.unesp.br

Abstract—The aging spontaneously hypertensive rat (SHR) is a model in which the transition from chronic stable left ventricular hypertrophy to overt heart failure can be observed. Although the mechanisms for impaired function in hypertrophied and failing cardiac muscle from the SHR have been studied, none accounts fully for the myocardial contractile abnormalities. The cardiac cytoskeleton has been implicated as a possible cause for myocardial dysfunction. If an increase in microtubules contributes to dysfunction, then myocardial microtubule disruption by colchicine should promote an improvement in cardiac performance. We studied the active and passive properties of isolated left ventricular papillary muscles from 18- to 24-month-old SHR with evidence of heart failure (SHR-F, n=6), age-matched SHR without heart failure (SHR-NF, n=6), and age-matched normotensive Wistar-Kyoto rats (WKY, n=5). Mechanical parameters were analyzed before and up to 90 minutes after the addition of colchicine (10-5, 10-4, and 10-3 mol/L). In the baseline state, active tension (AT) developed by papillary muscles from the WKY group was greater than for SHR-NF and SHR-F groups (WKY 5.69±1.47 g/mm2 [mean±SD], SHR-NF 3.41±1.05, SHR-F 2.87±0.26; SHR-NF and SHR-F P<0.05 versus WKY rats). The passive stiffness was greater in SHR-F than in the WKY and SHR-NF groups (central segment exponential stiffness constant, Kcs: SHR-F 70±25, SHR-NF 44±17, WKY 41±13 [mean±SD]; SHR-F P<0.05 versus SHR-NF and WKY rats). AT did not improve after 10, 20, and 30 minutes of exposure to colchicine (10-5, 10-4, and 10-3 mol/L) in any group. In the SHR-F group, AT and passive stiffness did not change after 30 to 90 minutes of colchicine exposure (10-4 mol/L). In summary, the data in this study fail to demonstrate improvement of intrinsic muscle function in SHR with heart failure after colchicine. Thus, in the SHR there is no evidence that colchicine-induced cardiac microtubular depolymerization affects the active or passive properties of hypertrophied or failing left ventricular myocardium.


Key Words: colchicine • function, myocardial • rats, inbred SHR • hypertrophy, cardiac • heart failure • muscle, papillary • muscle, isolated cardiac




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
D. Scholz, P. McDermott, M. Garnovskaya, T. N. Gallien, S. Huettelmaier, C. DeRienzo, and G. Cooper IV
Microtubule-associated protein-4 (MAP-4) inhibits microtubule-dependent distribution of mRNA in isolated neonatal cardiocytes
Cardiovasc Res, August 1, 2006; 71(3): 506 - 516.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Nishimura, S. Nagai, M. Katoh, H. Yamashita, Y. Saeki, J.-i. Okada, T. Hisada, R. Nagai, and S. Sugiura
Microtubules Modulate the Stiffness of Cardiomyocytes Against Shear Stress
Circ. Res., January 6, 2006; 98(1): 81 - 87.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. M. Warren, M. C. Jordan, K. P. Roos, P. R. Krzesinski, and M. L. Greaser
Titin isoform expression in normal and hypertensive myocardium
Cardiovasc Res, July 1, 2003; 59(1): 86 - 94.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. A. R. de Paiva, L. A. M. Zornoff, M. P. Okoshi, K. Okoshi, L. S. Matsubara, B. B. Matsubara, A. C. Cicogna, and A. O. Campana
Ventricular remodeling induced by retinoic acid supplementation in adult rats
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2242 - H2246.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. G. Kerfant, G. Vassort, and A. M. Gomez
Microtubule Disruption by Colchicine Reversibly Enhances Calcium Signaling in Intact Rat Cardiac Myocytes
Circ. Res., April 13, 2001; 88 (7): e59 - e65.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. C. Calaghan, J.-Y. Le Guennec, and E. White
Modulation of Ca2+ Signaling by Microtubule Disruption in Rat Ventricular Myocytes and Its Dependence on the Ruptured Patch-Clamp Configuration
Circ. Res., March 2, 2001; 88 (4): e32 - e37.
[Abstract] [Full Text] [PDF]